Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 2
2013 3
2014 3
2015 5
2016 2
2017 5
2018 7
2019 7
2020 10
2021 4
2022 4
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer.
Hsieh RC, Krishnan S, Wu RC, Boda AR, Liu A, Winkler M, Hsu WH, Lin SH, Hung MC, Chan LC, Bhanu KR, Srinivasamani A, De Azevedo RA, Chou YC, DePinho RA, Gubin M, Vilar E, Chen CH, Slay R, Jayaprakash P, Hegde SM, Hartley G, Lea ST, Prasad R, Morrow B, Couillault CA, Steiner M, Wang CC, Venkatesulu BP, Taniguchi C, Kim YSB, Chen J, Rudqvist NP, Curran MA. Hsieh RC, et al. Among authors: rudqvist np. Sci Immunol. 2022 Jun 10;7(72):eabl9330. doi: 10.1126/sciimmunol.abl9330. Epub 2022 Jun 10. Sci Immunol. 2022. PMID: 35687697 Free PMC article.
Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control.
Lhuillier C, Rudqvist NP, Yamazaki T, Zhang T, Charpentier M, Galluzzi L, Dephoure N, Clement CC, Santambrogio L, Zhou XK, Formenti SC, Demaria S. Lhuillier C, et al. Among authors: rudqvist np. J Clin Invest. 2021 Mar 1;131(5):e138740. doi: 10.1172/JCI138740. J Clin Invest. 2021. PMID: 33476307 Free PMC article.
Radiotherapy induces responses of lung cancer to CTLA-4 blockade.
Formenti SC, Rudqvist NP, Golden E, Cooper B, Wennerberg E, Lhuillier C, Vanpouille-Box C, Friedman K, Ferrari de Andrade L, Wucherpfennig KW, Heguy A, Imai N, Gnjatic S, Emerson RO, Zhou XK, Zhang T, Chachoua A, Demaria S. Formenti SC, et al. Among authors: rudqvist np. Nat Med. 2018 Dec;24(12):1845-1851. doi: 10.1038/s41591-018-0232-2. Epub 2018 Nov 5. Nat Med. 2018. PMID: 30397353 Free PMC article. Clinical Trial.
Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non-small cell lung cancer.
Wennerberg E, Mukherjee S, Spada S, Hung C, Agrusa CJ, Chen C, Valeta-Magara A, Rudqvist NP, Van Nest SJ, Kamel MK, Nasar A, Narula N, Mittal V, Markowitz GJ, Zhou XK, Adusumilli PS, Borczuk AC, White TE, Khan AG, Balderes PJ, Lorenz IC, Altorki N, Demaria S, McGraw TE, Stiles BM. Wennerberg E, et al. Among authors: rudqvist np. Sci Transl Med. 2022 Mar 16;14(636):eabe8195. doi: 10.1126/scitranslmed.abe8195. Epub 2022 Mar 16. Sci Transl Med. 2022. PMID: 35294260 Free PMC article.
Preface: More than two decades of modern tumor immunology.
Galluzzi L, Rudqvist NP. Galluzzi L, et al. Among authors: rudqvist np. Methods Enzymol. 2020;636:xvii-xxxvi. doi: 10.1016/S0076-6879(20)30114-2. Methods Enzymol. 2020. PMID: 32178830 No abstract available.
Preface: More than two decades of modern tumor immunology.
Galluzzi L, Rudqvist NP. Galluzzi L, et al. Among authors: rudqvist np. Methods Enzymol. 2020;635:xix-xxxviii. doi: 10.1016/S0076-6879(20)30077-X. Methods Enzymol. 2020. PMID: 32122557 No abstract available.
Preface: More than two decades of modern tumor immunology.
Galluzzi L, Rudqvist NP. Galluzzi L, et al. Among authors: rudqvist np. Methods Enzymol. 2020;632:xxiii-xlii. doi: 10.1016/S0076-6879(20)30043-4. Methods Enzymol. 2020. PMID: 32000917 No abstract available.
Preface: More than two decades of modern tumor immunology.
Galluzzi L, Rudqvist NP. Galluzzi L, et al. Among authors: rudqvist np. Methods Enzymol. 2020;631:xxiii-xlii. doi: 10.1016/S0076-6879(20)30020-3. Methods Enzymol. 2020. PMID: 31948570 No abstract available.
Preface: More than two decades of modern tumor immunology.
Galluzzi L, Rudqvist NP. Galluzzi L, et al. Among authors: rudqvist np. Methods Enzymol. 2019;629:xxi-xl. doi: 10.1016/S0076-6879(19)30459-8. Methods Enzymol. 2019. PMID: 31727259 No abstract available.
Hallmarks of Resistance to Immune-Checkpoint Inhibitors.
Karasarides M, Cogdill AP, Robbins PB, Bowden M, Burton EM, Butterfield LH, Cesano A, Hammer C, Haymaker CL, Horak CE, McGee HM, Monette A, Rudqvist NP, Spencer CN, Sweis RF, Vincent BG, Wennerberg E, Yuan J, Zappasodi R, Lucey VMH, Wells DK, LaVallee T. Karasarides M, et al. Among authors: rudqvist np. Cancer Immunol Res. 2022 Apr 1;10(4):372-383. doi: 10.1158/2326-6066.CIR-20-0586. Cancer Immunol Res. 2022. PMID: 35362046 Free PMC article.
53 results